Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ambu A/S Unsponsored ADR (AMBBY : OTC)

• Company Description    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark. Number of Employees: 5,384

• Price / Volume Information    Yesterday's Closing Price: $13.20 Daily Weekly Monthly 20 Day Moving Average: 155 shares Shares Outstanding: 234.97 (millions) Market Capitalization: $3,101.66 (millions) Beta: 0.94 52 Week High: $20.24 52 Week Low: $12.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.83% -2.67% 12 Week -21.33% -22.60% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BALTORPBAKKEN 13 - BALLERUP,G7 DK-2750 DNK ph: 45-7225-2000 fax: - anhj@ambu.com http://www.ambu.com

• General Corporate Information    Officers Britt Meelby Jensen - Chief Executive Officer Jorgen Jensen - Chairman Scott Heinzelman - President Graziela Malucelli - Chief Operations Officer Henrik Skak Bender - Chief Financial Officer Peer Information Ambu A/S Unsponsored ADR (MGLHQ) Ambu A/S Unsponsored ADR (AMBBY) Ambu A/S Unsponsored ADR (HMA.) Ambu A/S Unsponsored ADR (CPMIQ) Ambu A/S Unsponsored ADR (FPAMQ) Ambu A/S Unsponsored ADR (PSYS2) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HOSPITALS Sector: Medical CUSIP: 02337W109 SIC: 6770 Fiscal Year Fiscal Year End: September Last Reported Quarter: 09/01/25 Next Expected EPS Date: 01/29/26 Share - Related Items Shares Outstanding: 234.97 Most Recent Split Date: (:1) Beta: 0.94 Market Capitalization: $3,101.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.26% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.08 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.04 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 12/05/2025 - $0.03 Next EPS Report Date: 01/29/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 38.82 PEG Ratio: - Price Ratios Price/Book: 3.47 Price/Cash Flow: 21.34 Price / Sales: 3.47 EPS Growth vs. Year Ago Period: 187.50% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 12.37% vs. Previous Quarter: 0.19% ROE 12/31/25 - - 09/30/25 - 10.35 06/30/25 - 6.11 ROA 12/31/25 - - 09/30/25 - 8.20 06/30/25 - 4.83 Current Ratio 12/31/25 - - 09/30/25 - 2.72 06/30/25 - 2.90 Quick Ratio 12/31/25 - - 09/30/25 - 1.63 06/30/25 - 1.73 Operating Margin 12/31/25 - - 09/30/25 - 10.00 06/30/25 - 5.93 Net Margin 12/31/25 - - 09/30/25 - 10.00 06/30/25 - 5.93 Pre-Tax Margin 12/31/25 - - 09/30/25 - 12.51 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - 3.80 06/30/25 - 3.82 Inventory Turnover 12/31/25 - - 09/30/25 - 1.99 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.08 06/30/25 - 0.08 Debt-to-Capital 12/31/25 - - 09/30/25 - 7.18 06/30/25 - 7.21

Powered by Zacks Investment Research ©